Nath Alok, Prashanth Arun, Lal Hira, Kumar Sheo, Barai Sukanta, Gambhir Sanjay
Departments of Pulmonary Medicine.
Nuclear Medicine.
Nucl Med Commun. 2020 Mar;41(3):246-251. doi: 10.1097/MNM.0000000000001148.
The aim of this study was to assess the diagnostic yield of robotic-assisted computed tomography (CT)-guided F-FDG PET/CT-directed biopsy for the evaluation of intrathoracic space occupying lesions.
Twenty-four patients being evaluated for intrathoracic masses were included in the study. The indications were patients with unknown/likely primary detected from PET-CT, suspicious lesions identified from PET-CT in a known primary disease and fine needle aspiration cytology/CT-guided biopsy negative lesions with a high index of suspicion for malignancy. Biopsies were carried out with the help of automated radiology arm (ROBIO-EX) which is essentially a needle positioning and holding device. A two-day protocol was followed in which PET-CT scan was done on the first day, biopsy procedure was done on the next scheduled day. PET images were refused with the CT images done on the second day in the console by using manual alignment and then a biopsy was carried out with the help of a robotic arm. Primary outcome was histopathological yield from the obtained specimens.
Tissue yield was 100% (n = 24) and histopathological diagnosis rate was 96% (n = 23). Out of the 24 lesions biopsied 30% (n = 8) were benign and 70% (n = 16) turned out to be malignant. The complication rates were pneumothorax 4% (n = 1) and haemothorax 4% (n = 1).
Robotic-assisted CT-guided F-FDG PET/CT-directed biopsy is a useful and accurate technique for diagnostic evaluation of intrathoracic neoplasms with minimal complications rates as compared with conventional imaging techniques.
本研究旨在评估机器人辅助计算机断层扫描(CT)引导下F-FDG PET/CT导向活检对评估胸内占位性病变的诊断效能。
本研究纳入24例接受胸内肿块评估的患者。适应证包括PET-CT检查发现的原发灶不明/可能的原发灶、已知原发性疾病患者PET-CT检查发现的可疑病变以及细针穿刺细胞学检查/CT引导活检阴性但高度怀疑为恶性的病变。活检借助自动放射臂(ROBIO-EX)进行,该设备本质上是一种针定位和固定装置。采用为期两天的方案,第一天进行PET-CT扫描,第二天进行活检操作。在控制台通过手动对齐将第二天的CT图像与PET图像融合,然后借助机器人臂进行活检。主要观察指标是获取标本的组织病理学诊断率。
组织获取率为100%(n = 24),组织病理学诊断率为96%(n = 23)。在24例活检病变中,30%(n = 8)为良性,70%(n = 16)为恶性。并发症发生率为气胸4%(n = 1),血胸4%(n = 1)。
与传统成像技术相比,机器人辅助CT引导下F-FDG PET/CT导向活检是一种用于胸内肿瘤诊断评估的有用且准确的技术,并发症发生率极低。